Grace Therapeutics, Inc.
GRCE
Revenue
100.00M
▲100.00M∞%
-Assets
48.47M
▲25.51M▲111.12%
12 Months ChangeLiabilities
34.51M
▲19.77M▲134.20%
12 Months ChangeFree Cash Flow
-4.21M
▲19.06M▲81.92%
3 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2026-02-12
Form 8-K
ID: 0001140361-26-004927
2026-02-12
Form 10-Q
ID: 0001140361-26-004924
2026-01-12
Form 8-K
ID: 0001140361-26-000995
2025-11-13
Form 8-K
ID: 0001140361-25-041807
2025-11-13
Form 10-Q
ID: 0001140361-25-041804
2025-10-23
Form 8-K
ID: 0001140361-25-039020
2025-09-18
Form 8-K
ID: 0001140361-25-035337
2025-09-12
Form 8-K
ID: 0001140361-25-034845
2025-08-27
Form 8-K
ID: 0001140361-25-032847
2025-08-12
Form 8-K
ID: 0001140361-25-030400